76 related articles for article (PubMed ID: 30129055)
21. A positive feed-forward loop between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 signaling promotes proliferation and metastasis of clear cell renal cell carcinoma.
Zhai W; Zhu R; Ma J; Gong D; Zhang H; Zhang J; Chen Y; Huang Y; Zheng J; Xue W
Mol Cancer; 2019 Apr; 18(1):81. PubMed ID: 30953521
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
[TBL] [Abstract][Full Text] [Related]
23. LncRNA MALAT1 modified progression of clear cell kidney carcinoma (KIRC) by regulation of miR-194-5p/ACVR2B signaling.
Ye Y; Zhang F; Chen Q; Huang Z; Li M
Mol Carcinog; 2019 Feb; 58(2):279-292. PubMed ID: 30334578
[TBL] [Abstract][Full Text] [Related]
24. The downregulated long noncoding RNA
Wang C; Wang G; Zhang Z; Wang Z; Ren M; Wang X; Li H; Yu Y; Liu J; Cai L; Li Y; Zhang D; Zhang C
Onco Targets Ther; 2018; 11():5631-5646. PubMed ID: 30254456
[TBL] [Abstract][Full Text] [Related]
25. Pro-Angiogenic and Pro-Inflammatory Regulation by lncRNA MCM3AP-AS1-Mediated Upregulation of DPP4 in Clear Cell Renal Cell Carcinoma.
Qiu L; Ma Y; Yang Y; Ren X; Wang D; Jia X
Front Oncol; 2020; 10():705. PubMed ID: 32714856
[TBL] [Abstract][Full Text] [Related]
26. HOTAIRM1 lncRNA is downregulated in clear cell renal cell carcinoma and inhibits the hypoxia pathway.
Hamilton MJ; Young M; Jang K; Sauer S; Neang VE; King AT; Girke T; Martinez E
Cancer Lett; 2020 Mar; 472():50-58. PubMed ID: 31862408
[TBL] [Abstract][Full Text] [Related]
27. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH
Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752
[TBL] [Abstract][Full Text] [Related]
28. A prediction of the CRNDE role by modulating NF-κB pathway in inflammatory bowel disease (IBD).
Kazemifard N; Farmani M; Baradaran Ghavami S; Kazemi M; Shahrokh S; Asadzadeh Aghdaei H; Zali M
Biochem Biophys Rep; 2024 Jul; 38():101731. PubMed ID: 38766384
[TBL] [Abstract][Full Text] [Related]
29. SCCPMD: Probability matrix decomposition method subject to corrected similarity constraints for inferring long non-coding RNA-disease associations.
Lin L; Chen R; Zhu Y; Xie W; Jing H; Chen L; Zou M
Front Microbiol; 2022; 13():1093615. PubMed ID: 36713213
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic lncRNA BBOX1-AS1 promotes PHF8-mediated autophagy and elicits sorafenib resistance in hepatocellular carcinoma.
Tao H; Zhang Y; Li J; Liu J; Yuan T; Wang W; Liang H; Zhang E; Huang Z
Mol Ther Oncolytics; 2023 Mar; 28():88-103. PubMed ID: 36699616
[TBL] [Abstract][Full Text] [Related]
31. The long non-coding RNA
Ding X; Zhang Y; Liang J; Yin J; Akbar N; Miguel V; Zhou Y
Ann Transl Med; 2022 Aug; 10(15):835. PubMed ID: 36034978
[TBL] [Abstract][Full Text] [Related]
32. CRNDE silencing promotes apoptosis and enhances cisplatin sensitivity of colorectal carcinoma cells by inhibiting the Akt/mTORC1-mediated Warburg effect.
Yang W; Wang Y; Tao C; Li Y; Cao S; Yang X
Oncol Lett; 2022 Feb; 23(2):70. PubMed ID: 35069879
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA CRNDE exacerbates NPC advancement mediated by the miR-545-5p/CCND2 axis.
Ge S; Jiang C; Li M; Cheng Z; Feng X
Cancer Cell Int; 2021 Dec; 21(1):650. PubMed ID: 34863152
[TBL] [Abstract][Full Text] [Related]
34.
Liu Q; Lei C
Ann Med; 2021 Dec; 53(1):2153-2164. PubMed ID: 34783622
[TBL] [Abstract][Full Text] [Related]
35. A New Light on Potential Therapeutic Targets for Colorectal Cancer Treatment.
Tsai WL; Wang CY; Lee YC; Tang WC; Anuraga G; Ta HDK; Wu YF; Lee KH
Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680556
[TBL] [Abstract][Full Text] [Related]
36. The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis.
Zhou Y; Zhang Z; Wo M; Xu W
Bioengineered; 2021 Dec; 12(1):8994-9005. PubMed ID: 34643163
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA colorectal neoplasia differentially expressed correlates negatively with miR-33a and miR-495 and positively with inflammatory cytokines in asthmatic children.
Li W; Wang X; Sun S; An H
Clin Respir J; 2021 Nov; 15(11):1175-1184. PubMed ID: 34288494
[TBL] [Abstract][Full Text] [Related]
38. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma.
Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C
Front Oncol; 2021; 11():640150. PubMed ID: 33869028
[TBL] [Abstract][Full Text] [Related]
39. Long Non-Coding RNA PCED1B-AS1 Promotes the Progression of Clear Cell Renal Cell Carcinoma Through miR-484/ZEB1 Axis.
Qin J; Zhu T; Wu W; Chen H; He Y
Onco Targets Ther; 2021; 14():393-402. PubMed ID: 33469315
[TBL] [Abstract][Full Text] [Related]
40. CRNDE Contributes Cervical Cancer Progression by Regulating miR-4262/ZEB1 Axis.
Ren L; Yang S; Cao Q; Tian J
Onco Targets Ther; 2021; 14():355-366. PubMed ID: 33469312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
